DONNELL SHARPE: Open Payments
NPI 1720234578 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,643 in 14 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $480 · 2025 $1,643
Food & beverage: $1,643
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 2 | $254 |
| Janssen Biotech, Inc. | 2 | $152 |
| Ipsen Biopharmaceuticals, Inc | 1 | $148 |
| Legend Biotech USA Inc. | 1 | $139 |
| Regeneron Healthcare Solutions, Inc. | 1 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Kite Pharma, Inc. | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| Gilead Sciences, Inc. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
Products named: Somatuline Depot, RYBREVANT, CARVYKTI, TEVIMBRA, LIBTAYO, BRUKINSA, Yescarta, Nubeqa.
Industry payments across KY — which companies pay providers there.
